Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years
A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women und...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Sykes, Peter H. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
19993 |
|---|
| Übergeordnetes Werk: |
Enthalten in: IS - Domingues, Sara ELSEVIER, 2018, AJOG, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:226 ; year:2022 ; number:2 ; pages:2221-22213 ; extent:19993 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ajog.2021.09.009 |
|---|
| Katalog-ID: |
ELV056624905 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV056624905 | ||
| 003 | DE-627 | ||
| 005 | 20230626043654.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220205s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajog.2021.09.009 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica |
| 035 | |a (DE-627)ELV056624905 | ||
| 035 | |a (ELSEVIER)S0002-9378(21)01006-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 100 | 1 | |a Sykes, Peter H. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| 264 | 1 | |c 2022transfer abstract | |
| 300 | |a 19993 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. | ||
| 520 | |a A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. | ||
| 650 | 7 | |a young women |2 Elsevier | |
| 650 | 7 | |a observational management |2 Elsevier | |
| 650 | 7 | |a cervical abnormalities |2 Elsevier | |
| 650 | 7 | |a prospective multicenter study |2 Elsevier | |
| 700 | 1 | |a Simcock, Bryony J. |4 oth | |
| 700 | 1 | |a Innes, Carrie R. |4 oth | |
| 700 | 1 | |a Harker, Dianne |4 oth | |
| 700 | 1 | |a Williman, Jonathan A. |4 oth | |
| 700 | 1 | |a Whitehead, Martin |4 oth | |
| 700 | 1 | |a van der Griend, Rachael A. |4 oth | |
| 700 | 1 | |a Lawton, Beverley A. |4 oth | |
| 700 | 1 | |a Hibma, Merilyn |4 oth | |
| 700 | 1 | |a Fitzgerald, Peter |4 oth | |
| 700 | 1 | |a Dudley, Narena M. |4 oth | |
| 700 | 1 | |a Petrich, Simone |4 oth | |
| 700 | 1 | |a Eva, Lois |4 oth | |
| 700 | 1 | |a Bergzoll, Cecile |4 oth | |
| 700 | 1 | |a Kathuria, Jyoti |4 oth | |
| 700 | 1 | |a McPherson, Georgina |4 oth | |
| 700 | 1 | |a Tristram, Amanda |4 oth | |
| 700 | 1 | |a Faherty, Jim |4 oth | |
| 700 | 1 | |a Hardie, Donna |4 oth | |
| 700 | 1 | |a Robertson, Anne |4 oth | |
| 700 | 1 | |a Robertson, Vicki |4 oth | |
| 700 | 1 | |a Pather, Selvan |4 oth | |
| 700 | 1 | |a Wrede, C. David |4 oth | |
| 700 | 1 | |a Gastrell, Flora |4 oth | |
| 700 | 1 | |a Fentiman, Gary |4 oth | |
| 700 | 1 | |a John, Michael |4 oth | |
| 700 | 1 | |a White, Elaine |4 oth | |
| 700 | 1 | |a Parker, Catherine |4 oth | |
| 700 | 1 | |a Sadler, Lynn |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Domingues, Sara ELSEVIER |t IS |d 2018 |d AJOG |g Orlando, Fla |w (DE-627)ELV000288284 |
| 773 | 1 | 8 | |g volume:226 |g year:2022 |g number:2 |g pages:2221-22213 |g extent:19993 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ajog.2021.09.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 226 |j 2022 |e 2 |h 2221-22213 |g 19993 |y 226.2022, 2, 222.e1-, (19993 S.) | ||
| author_variant |
p h s ph phs |
|---|---|
| matchkey_str |
sykespeterhsimcockbryonyjinnescarrierhar:2022----:rdcigersinfevclnreihlanolsar |
| hierarchy_sort_str |
2022transfer abstract |
| publishDate |
2022 |
| allfields |
10.1016/j.ajog.2021.09.009 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica (DE-627)ELV056624905 (ELSEVIER)S0002-9378(21)01006-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Sykes, Peter H. verfasserin aut Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years 2022transfer abstract 19993 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Elsevier Simcock, Bryony J. oth Innes, Carrie R. oth Harker, Dianne oth Williman, Jonathan A. oth Whitehead, Martin oth van der Griend, Rachael A. oth Lawton, Beverley A. oth Hibma, Merilyn oth Fitzgerald, Peter oth Dudley, Narena M. oth Petrich, Simone oth Eva, Lois oth Bergzoll, Cecile oth Kathuria, Jyoti oth McPherson, Georgina oth Tristram, Amanda oth Faherty, Jim oth Hardie, Donna oth Robertson, Anne oth Robertson, Vicki oth Pather, Selvan oth Wrede, C. David oth Gastrell, Flora oth Fentiman, Gary oth John, Michael oth White, Elaine oth Parker, Catherine oth Sadler, Lynn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:226 year:2022 number:2 pages:2221-22213 extent:19993 https://doi.org/10.1016/j.ajog.2021.09.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2022 2 2221-22213 19993 226.2022, 2, 222.e1-, (19993 S.) |
| spelling |
10.1016/j.ajog.2021.09.009 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica (DE-627)ELV056624905 (ELSEVIER)S0002-9378(21)01006-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Sykes, Peter H. verfasserin aut Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years 2022transfer abstract 19993 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Elsevier Simcock, Bryony J. oth Innes, Carrie R. oth Harker, Dianne oth Williman, Jonathan A. oth Whitehead, Martin oth van der Griend, Rachael A. oth Lawton, Beverley A. oth Hibma, Merilyn oth Fitzgerald, Peter oth Dudley, Narena M. oth Petrich, Simone oth Eva, Lois oth Bergzoll, Cecile oth Kathuria, Jyoti oth McPherson, Georgina oth Tristram, Amanda oth Faherty, Jim oth Hardie, Donna oth Robertson, Anne oth Robertson, Vicki oth Pather, Selvan oth Wrede, C. David oth Gastrell, Flora oth Fentiman, Gary oth John, Michael oth White, Elaine oth Parker, Catherine oth Sadler, Lynn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:226 year:2022 number:2 pages:2221-22213 extent:19993 https://doi.org/10.1016/j.ajog.2021.09.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2022 2 2221-22213 19993 226.2022, 2, 222.e1-, (19993 S.) |
| allfields_unstemmed |
10.1016/j.ajog.2021.09.009 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica (DE-627)ELV056624905 (ELSEVIER)S0002-9378(21)01006-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Sykes, Peter H. verfasserin aut Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years 2022transfer abstract 19993 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Elsevier Simcock, Bryony J. oth Innes, Carrie R. oth Harker, Dianne oth Williman, Jonathan A. oth Whitehead, Martin oth van der Griend, Rachael A. oth Lawton, Beverley A. oth Hibma, Merilyn oth Fitzgerald, Peter oth Dudley, Narena M. oth Petrich, Simone oth Eva, Lois oth Bergzoll, Cecile oth Kathuria, Jyoti oth McPherson, Georgina oth Tristram, Amanda oth Faherty, Jim oth Hardie, Donna oth Robertson, Anne oth Robertson, Vicki oth Pather, Selvan oth Wrede, C. David oth Gastrell, Flora oth Fentiman, Gary oth John, Michael oth White, Elaine oth Parker, Catherine oth Sadler, Lynn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:226 year:2022 number:2 pages:2221-22213 extent:19993 https://doi.org/10.1016/j.ajog.2021.09.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2022 2 2221-22213 19993 226.2022, 2, 222.e1-, (19993 S.) |
| allfieldsGer |
10.1016/j.ajog.2021.09.009 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica (DE-627)ELV056624905 (ELSEVIER)S0002-9378(21)01006-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Sykes, Peter H. verfasserin aut Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years 2022transfer abstract 19993 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Elsevier Simcock, Bryony J. oth Innes, Carrie R. oth Harker, Dianne oth Williman, Jonathan A. oth Whitehead, Martin oth van der Griend, Rachael A. oth Lawton, Beverley A. oth Hibma, Merilyn oth Fitzgerald, Peter oth Dudley, Narena M. oth Petrich, Simone oth Eva, Lois oth Bergzoll, Cecile oth Kathuria, Jyoti oth McPherson, Georgina oth Tristram, Amanda oth Faherty, Jim oth Hardie, Donna oth Robertson, Anne oth Robertson, Vicki oth Pather, Selvan oth Wrede, C. David oth Gastrell, Flora oth Fentiman, Gary oth John, Michael oth White, Elaine oth Parker, Catherine oth Sadler, Lynn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:226 year:2022 number:2 pages:2221-22213 extent:19993 https://doi.org/10.1016/j.ajog.2021.09.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2022 2 2221-22213 19993 226.2022, 2, 222.e1-, (19993 S.) |
| allfieldsSound |
10.1016/j.ajog.2021.09.009 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica (DE-627)ELV056624905 (ELSEVIER)S0002-9378(21)01006-1 DE-627 ger DE-627 rakwb eng 570 VZ BIODIV DE-30 fid Sykes, Peter H. verfasserin aut Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years 2022transfer abstract 19993 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Elsevier Simcock, Bryony J. oth Innes, Carrie R. oth Harker, Dianne oth Williman, Jonathan A. oth Whitehead, Martin oth van der Griend, Rachael A. oth Lawton, Beverley A. oth Hibma, Merilyn oth Fitzgerald, Peter oth Dudley, Narena M. oth Petrich, Simone oth Eva, Lois oth Bergzoll, Cecile oth Kathuria, Jyoti oth McPherson, Georgina oth Tristram, Amanda oth Faherty, Jim oth Hardie, Donna oth Robertson, Anne oth Robertson, Vicki oth Pather, Selvan oth Wrede, C. David oth Gastrell, Flora oth Fentiman, Gary oth John, Michael oth White, Elaine oth Parker, Catherine oth Sadler, Lynn oth Enthalten in Elsevier Domingues, Sara ELSEVIER IS 2018 AJOG Orlando, Fla (DE-627)ELV000288284 volume:226 year:2022 number:2 pages:2221-22213 extent:19993 https://doi.org/10.1016/j.ajog.2021.09.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA AR 226 2022 2 2221-22213 19993 226.2022, 2, 222.e1-, (19993 S.) |
| language |
English |
| source |
Enthalten in IS Orlando, Fla volume:226 year:2022 number:2 pages:2221-22213 extent:19993 |
| sourceStr |
Enthalten in IS Orlando, Fla volume:226 year:2022 number:2 pages:2221-22213 extent:19993 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
young women observational management cervical abnormalities prospective multicenter study |
| dewey-raw |
570 |
| isfreeaccess_bool |
false |
| container_title |
IS |
| authorswithroles_txt_mv |
Sykes, Peter H. @@aut@@ Simcock, Bryony J. @@oth@@ Innes, Carrie R. @@oth@@ Harker, Dianne @@oth@@ Williman, Jonathan A. @@oth@@ Whitehead, Martin @@oth@@ van der Griend, Rachael A. @@oth@@ Lawton, Beverley A. @@oth@@ Hibma, Merilyn @@oth@@ Fitzgerald, Peter @@oth@@ Dudley, Narena M. @@oth@@ Petrich, Simone @@oth@@ Eva, Lois @@oth@@ Bergzoll, Cecile @@oth@@ Kathuria, Jyoti @@oth@@ McPherson, Georgina @@oth@@ Tristram, Amanda @@oth@@ Faherty, Jim @@oth@@ Hardie, Donna @@oth@@ Robertson, Anne @@oth@@ Robertson, Vicki @@oth@@ Pather, Selvan @@oth@@ Wrede, C. David @@oth@@ Gastrell, Flora @@oth@@ Fentiman, Gary @@oth@@ John, Michael @@oth@@ White, Elaine @@oth@@ Parker, Catherine @@oth@@ Sadler, Lynn @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000288284 |
| dewey-sort |
3570 |
| id |
ELV056624905 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056624905</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626043654.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220205s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2021.09.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056624905</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(21)01006-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sykes, Peter H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">19993</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">young women</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">observational management</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cervical abnormalities</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prospective multicenter study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simcock, Bryony J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Innes, Carrie R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harker, Dianne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williman, Jonathan A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Whitehead, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van der Griend, Rachael A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawton, Beverley A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hibma, Merilyn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fitzgerald, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dudley, Narena M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petrich, Simone</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eva, Lois</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bergzoll, Cecile</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kathuria, Jyoti</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McPherson, Georgina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tristram, Amanda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faherty, Jim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hardie, Donna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robertson, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robertson, Vicki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pather, Selvan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wrede, C. David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gastrell, Flora</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fentiman, Gary</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">John, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">White, Elaine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parker, Catherine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sadler, Lynn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:226</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:2221-22213</subfield><subfield code="g">extent:19993</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2021.09.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">226</subfield><subfield code="j">2022</subfield><subfield code="e">2</subfield><subfield code="h">2221-22213</subfield><subfield code="g">19993</subfield><subfield code="y">226.2022, 2, 222.e1-, (19993 S.)</subfield></datafield></record></collection>
|
| author |
Sykes, Peter H. |
| spellingShingle |
Sykes, Peter H. ddc 570 fid BIODIV Elsevier young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| authorStr |
Sykes, Peter H. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000288284 |
| format |
electronic Article |
| dewey-ones |
570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
570 VZ BIODIV DE-30 fid Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study Elsevier |
| topic |
ddc 570 fid BIODIV Elsevier young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study |
| topic_unstemmed |
ddc 570 fid BIODIV Elsevier young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study |
| topic_browse |
ddc 570 fid BIODIV Elsevier young women Elsevier observational management Elsevier cervical abnormalities Elsevier prospective multicenter study |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b j s bj bjs c r i cr cri d h dh j a w ja jaw m w mw d g r a v dgra dgrav b a l ba bal m h mh p f pf n m d nm nmd s p sp l e le c b cb j k jk g m gm a t at j f jf d h dh a r ar v r vr s p sp c d w cd cdw f g fg g f gf m j mj e w ew c p cp l s ls |
| hierarchy_parent_title |
IS |
| hierarchy_parent_id |
ELV000288284 |
| dewey-tens |
570 - Life sciences; biology |
| hierarchy_top_title |
IS |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000288284 |
| title |
Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| ctrlnum |
(DE-627)ELV056624905 (ELSEVIER)S0002-9378(21)01006-1 |
| title_full |
Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| author_sort |
Sykes, Peter H. |
| journal |
IS |
| journalStr |
IS |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
2221 |
| author_browse |
Sykes, Peter H. |
| container_volume |
226 |
| physical |
19993 |
| class |
570 VZ BIODIV DE-30 fid |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sykes, Peter H. |
| doi_str_mv |
10.1016/j.ajog.2021.09.009 |
| dewey-full |
570 |
| title_sort |
predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| title_auth |
Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| abstract |
A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. |
| abstractGer |
A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. |
| abstract_unstemmed |
A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
2 |
| title_short |
Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years |
| url |
https://doi.org/10.1016/j.ajog.2021.09.009 |
| remote_bool |
true |
| author2 |
Simcock, Bryony J. Innes, Carrie R. Harker, Dianne Williman, Jonathan A. Whitehead, Martin van der Griend, Rachael A. Lawton, Beverley A. Hibma, Merilyn Fitzgerald, Peter Dudley, Narena M. Petrich, Simone Eva, Lois Bergzoll, Cecile Kathuria, Jyoti McPherson, Georgina Tristram, Amanda Faherty, Jim Hardie, Donna Robertson, Anne Robertson, Vicki Pather, Selvan Wrede, C. David Gastrell, Flora Fentiman, Gary John, Michael White, Elaine Parker, Catherine Sadler, Lynn |
| author2Str |
Simcock, Bryony J. Innes, Carrie R. Harker, Dianne Williman, Jonathan A. Whitehead, Martin van der Griend, Rachael A. Lawton, Beverley A. Hibma, Merilyn Fitzgerald, Peter Dudley, Narena M. Petrich, Simone Eva, Lois Bergzoll, Cecile Kathuria, Jyoti McPherson, Georgina Tristram, Amanda Faherty, Jim Hardie, Donna Robertson, Anne Robertson, Vicki Pather, Selvan Wrede, C. David Gastrell, Flora Fentiman, Gary John, Michael White, Elaine Parker, Catherine Sadler, Lynn |
| ppnlink |
ELV000288284 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ajog.2021.09.009 |
| up_date |
2024-07-06T20:56:14.554Z |
| _version_ |
1803864636974432256 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV056624905</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626043654.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220205s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ajog.2021.09.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001672.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV056624905</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0002-9378(21)01006-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sykes, Peter H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Predicting regression of cervical intraepithelial neoplasia grade 2 in women under 25 years</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">19993</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A number of retrospective and prospective studies have documented substantial rates of regression in cervical intraepithelial neoplasia grade 2 lesions in young women. Initial observational management of cervical intraepithelial neoplasia grade 2 is increasingly accepted as appropriate for women under 25 years of age with screen-detected abnormalities and is included in a number of clinical guidelines. However, there has been a paucity of large prospective studies on observational management with strict inclusion criteria. A number of important questions remain, specifically regarding the clinical variables that are associated with the risk of progression or persistence of disease. To investigate these factors and to ensure that young women with cervical intraepithelial neoplasia grade 2 undergoing observational management were being managed in a well-monitored and an appropriately informed fashion, we conducted a large, multicenter prospective study on observational management of cervical intraepithelial neoplasia grade 2 in women under 25 years.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">young women</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">observational management</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">cervical abnormalities</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">prospective multicenter study</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simcock, Bryony J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Innes, Carrie R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harker, Dianne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williman, Jonathan A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Whitehead, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">van der Griend, Rachael A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lawton, Beverley A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hibma, Merilyn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fitzgerald, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dudley, Narena M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Petrich, Simone</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eva, Lois</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bergzoll, Cecile</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kathuria, Jyoti</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McPherson, Georgina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tristram, Amanda</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Faherty, Jim</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hardie, Donna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robertson, Anne</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Robertson, Vicki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pather, Selvan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wrede, C. David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gastrell, Flora</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fentiman, Gary</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">John, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">White, Elaine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parker, Catherine</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sadler, Lynn</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Domingues, Sara ELSEVIER</subfield><subfield code="t">IS</subfield><subfield code="d">2018</subfield><subfield code="d">AJOG</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV000288284</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:226</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:2221-22213</subfield><subfield code="g">extent:19993</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ajog.2021.09.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">226</subfield><subfield code="j">2022</subfield><subfield code="e">2</subfield><subfield code="h">2221-22213</subfield><subfield code="g">19993</subfield><subfield code="y">226.2022, 2, 222.e1-, (19993 S.)</subfield></datafield></record></collection>
|
| score |
7.4002523 |